Dr. Yuezhen Wang 王跃珍
Chief Physician
Department of Thoracic Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiation therapy for breast, liver, and lung cancers. Prevention and treatment of radiation therapy complications.
Dr. Wang graduated from Bethune Medical University in 1993 and earned a master’s degree in integrated Chinese and Western medicine in 2006. With 18 years of experience, Dr. Wang focuses on radiation therapy for chest tumors, including breast, esophageal, and lung cancers. Research interests include basic and clinical studies of breast and esophageal cancers.
Name order: in Chinese the family name comes first (Wang Yuezhen). Papers usually list the name as Yuezhen Wang or Wang Y.
Selected publications
28 papers on PubMed matched by name and affiliation; 9 as first or senior author since 2016. Most recent first- or senior-author papers:
- Mol Biotechnol, 2022 (first author): MiR-125b-5p/TPD52 Axis Affects Proliferation, Migration and Invasion of Breast Cancer Cells. PubMed 35320453
- J Oncol, 2022 (senior author): Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer. PubMed 35444698
- Exp Lung Res, 2022 (senior author): 3,3'-Diindolylmethane attenuates inflammation and fibrosis in radiation-induced lung injury by regulating NF-κB/TGF-β/Smad signaling pathways. PubMed 35594367
- J Radiat Res, 2022 (senior author): Outcomes of SBRT for lung oligo-recurrence of non-small cell lung cancer: a retrospective analysis. PubMed 34958672
- Stem Cell Res Ther, 2021 (senior author): Adipose tissue-derived stem cells in breast reconstruction: a brief review on biology and translation. PubMed 33407902
- Biosci Rep, 2020 (senior author): Prognostic value of immune checkpoint molecules in breast cancer. PubMed 32602545
- BMC Pulm Med, 2019 (senior author): Outcomes of stereotactic body radiotherapy versus lobectomy for stage I non-small cell lung cancer: a propensity score matching analysis. PubMed 31118007
- Technol Cancer Res Treat, 2018 (senior author): DCE-MRI-Derived Volume Transfer Constant (K(trans)) and DWI Apparent Diffusion Coefficient as Predictive Markers of Short- and Long-Term Efficacy of Chemoradiotherapy in Patients With Esophageal Cancer. PubMed 29642773
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion